HRSA Proposes To Again Delay Implementing Rule On 340B Ceiling Prices, Penalties

By Michelle M. Stein / August 17, 2017 at 8:34 PM
The Health Resources and Services Administration proposed another delay, this time until July 2018, of a rule on the 340B drug discount program that sets ceiling prices and civil monetary penalties as the agency considers changing the regulation. Some drug makers want the agency to revamp the rule but 340B hospitals want HRSA to implement it. HRSA finished the rule shortly before President Obama left office, and this proposal marks the fourth time the Trump administration has tried to delayed...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.